DarioHealth (DRIO) Expected to Announce Earnings on Thursday

DarioHealth (NASDAQ:DRIO) is projected to release its earnings data before the market opens on Thursday, March 27th. Analysts expect DarioHealth to post earnings of ($0.24) per share and revenue of $7.39 million for the quarter. Persons interested in participating in the company’s earnings conference call can do so using this link.

DarioHealth Trading Up 1.7 %

Shares of DRIO stock opened at $0.70 on Tuesday. The company has a current ratio of 1.57, a quick ratio of 1.32 and a debt-to-equity ratio of 0.35. The stock has a market capitalization of $29.10 million, a price-to-earnings ratio of -0.74 and a beta of 1.42. DarioHealth has a 12-month low of $0.56 and a 12-month high of $1.93. The stock’s 50-day moving average price is $0.68 and its 200-day moving average price is $0.81.

Analyst Ratings Changes

A number of analysts have issued reports on DRIO shares. Stifel Nicolaus reduced their price objective on DarioHealth from $3.50 to $2.00 and set a “buy” rating on the stock in a research note on Tuesday, March 11th. TD Cowen cut shares of DarioHealth from a “buy” rating to a “hold” rating and reduced their price target for the stock from $2.00 to $1.00 in a research report on Wednesday, January 29th.

About DarioHealth

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.